NCT02695966View on ClinicalTrials.gov

EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Pancreatic Cancer
Interventions
PROCEDURE

Whipples Surgery

Whipples Surgery

Trial Locations (1)

CB2 2QQ

Addenbrooke's Hospital, Cambridge

All Listed Sponsors
collaborator

Cancer Research UK Cambridge Institute

OTHER

collaborator

University of Cambridge

OTHER

lead

Cambridge University Hospitals NHS Foundation Trust

OTHER

NCT02695966 - EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer | Biotech Hunter | Biotech Hunter